We work hard to address neglected tropical diseases (NTDs) that disproportionately impact the world’s poor and marginalized populations. In 2016 nearly 250 of our most experienced scientists are collaborating with partners and dedicating more than 21,500 pro-bono hours to drug development projects, advisory boards and compound screening to help solve NTDs.

We are committed to reducing our impact on the environment. Over the last two years we reduced total carbon dioxide equivalent emissions by 13 percent.